Ships: within 1 business day
Sehgal NKR et al. · JAMA network open ·
The study looked at people who posted on social media about using GLP-3 R, a compound they obtained without approval. It was a cross-sectional design, meaning the researchers collected reports at a single point in time rather than following anyone forward. The data came from the users' own accounts of their side effects, not from clinical measurement. The abstract does not state how many users were included or over what period the reports were gathered.
Compounds